Gemelli Biotech
Raleigh, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Gemelli Biotech
Sign up to see every warm intro you have to Gemelli Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gemelli Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Gemelli Biotech was founded in 2018 by Mark Pimentel.
MP
Mark PimentelFounder
MM
Matthew MitchoExecutive
Board
JA
John A. NeczesnyBoard director
OL
Oded LevyBoard director
RA
Ritish AgarwalBoard director
JL
James LaurBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$28.5M disclosed across 3 rounds · 2019–2021
▶$21.2MraisedDec 2024 · 128 investors · BiotechnologyRule 506(b)
▶$21.2MraisedDec 2024 · 128 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John A. NeczesnyDirector
- Matthew MitchoExecutive Officer, Director
- Oded LevyDirector
- Ritish AgarwalDirector
- James LaurDirector
- Offering amount
- $23.9M
- Amount sold
- $21.2M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedMar 2021 · 85 investors · BiotechnologyRule 506(b)
▶$5.5MraisedMar 2021 · 85 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew MitchoExecutive Officer, Director
- Mark PimentelExecutive Officer, Director
- James LaurDirector
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.9MraisedJun 2019 · 13 investors · BiotechnologyRule 506(b)
▶$1.9MraisedJun 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew MitchoExecutive Officer, Director
- Mark PimentelExecutive Officer, Director
- James LaurDirector
- Offering amount
- $3M
- Amount sold
- $1.9M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Gemelli Biotech?
- Gemelli Biotech was founded by Mark Pimentel in 2018.
- Who are Gemelli Biotech's investors?
- Gemelli Biotech's investors include LOUD Capital.
- How much funding has Gemelli Biotech raised?
- Gemelli Biotech has disclosed $28.5M raised across 3 rounds.
- Where is Gemelli Biotech headquartered?
- Gemelli Biotech is headquartered in Raleigh, US.
